Study shows restored immunity for cancer-related fungal infections

July 8, 2014

Sleeping Beauty and fungal infections – not two items one would normally associate together, but for immunocompromised cancer patients they may prove to be a helpful combination.

A study at The University of Texas MD Anderson Cancer Center used the Sleeping Beauty gene transfer system to modify T in hopes of fighting major life-threatening infections caused by invasive Aspergillus fungus. Results of the study appear in today's issue of the Proceedings of the National Academy of Sciences (PNAS).

This type of gene therapy is already being used to recognize antigens associated with tumors. Clinical trials at MD Anderson were the first to use Sleeping Beauty to customize immune system T cells to attack specific types of leukemia and lymphoma.

The Aspergillus study, led by Laurence Cooper, M.D., Ph.D., professor in Pediatrics at MD Anderson, shows that it may also be effective for combatting that can be deadly for immunosuppressed patients such as those receiving transplants. The transplants are used to treat cancers of the blood or bone marrow such as leukemia, lymphoma, and multiple myeloma.

Cooper's study, which included collaboration with Dimitrios Kontoyiannis, M.D., Sc.D., professor in the Department of Infectious Diseases, employed a novel method for inhibiting growth of fungus. The Sleeping Beauty system, developed at the University of Minnesota, offered a fresh approach to genetically modifying T cells for human use which is being piloted at MD Anderson for immunotherapy.

The team harnessed Sleeping Beauty to engineer human T cells to express receptors known as chimeric antigen receptors (CARs) which redirected the killing machinery of the T cells. T cells displaying CAR targeted sugar molecules in the Aspergillus cell walls, killing the fungus.

"Mortality associated with invasive Aspergillus remains unacceptably high, especially in hematopoietic stem cell transplant recipients," said Kontoyiannis. "While antifungal therapies are available, the patient's own weakened immune system and emerging resistance to antifungals compromise the drugs' effectiveness. There is a dire need for effective immune enhancements strategies for the treatment of opportunistic fungal infections in patients with profound and persistent immune defects."

Cooper said that new approaches for treating invasive Aspergillus are urgently needed. Since use of CARs has resulted in successful treatment of patients with B-cell malignancies, his team sought to determine if a CAR could be developed to redirect T-cell specificity to fungus.

The Sleeping Beauty gene transfer system earned its name by its ability to "awaken" certain DNA sequences known as transposon. Researchers find transposon useful as a means to alter DNA inside human cells. Sleeping Beauty uses transposon in a "cut and paste" approach to relocating genetic material.

"We demonstrated a new approach for Aspergillus immunotherapy based on redirecting T-cell specificity through a CAR that recognizes carbohydrate antigen on the fungal cell wall," said Cooper. "The T cells expressing the CAR can be manipulated in a manner suitable for human application, enabling this immunology to be translated into immunotherapy."

The approach has implications for genetically modifying T cells to target carbohydrate, and thus broadening their application in the investigational treatment of pathogens as well as malignancies.

Explore further: Novel gene therapy enables persistent anti-tumor immune response

More information: Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection, PNAS, www.pnas.org/cgi/doi/10.1073/pnas.1312789111

Related Stories

Novel gene therapy enables persistent anti-tumor immune response

October 9, 2013
Cancer immunotherapy can successfully use the body's own immune system to kill tumor cells. But some current approaches to stimulate an antitumor immune response are short-lived, with limited clinical effectiveness. A new ...

New possibilities for leukemia therapy with a novel mode of leukemia cell recognition

June 24, 2014
Scientists at A*STAR's Singapore Immunology Network (SIgN) have discovered a new class of lipids in the leukaemia cells that are detected by a unique group of immune cells. By recognising the lipids, the immune cells stimulate ...

Transfer of a few immune cells can protect immunodeficient patients

June 17, 2014
When patients have to undergo a bone marrow transplant, the procedure weakens their immune system. Viruses that are usually kept in check in a healthy immune system may then cause potentially fatal infections. Scientists ...

US regulators fast-track novel leukemia therapy

July 7, 2014
US regulators on Monday put an experimental immunotherapy agent on the fast track to market approval, after 89 percent of leukemia patients in early trials saw their cancers disappear.

New approach identifies cancer mutations as targets of effective melanoma immunotherapy

July 1, 2014
A new approach demonstrated that the recognition of unique cancer mutations appeared to be responsible for complete cancer regressions in two metastatic melanoma patients treated with a type of immunotherapy called adoptive ...

Fungal infections can trigger and exacerbate asthma

September 2, 2013
(Medical Xpress)—A common fungal infection can trigger asthma and make it much worse by way of a route not targeted by existing asthma drugs, report researchers at Boston Children's Hospital. Their findings, published online ...

Recommended for you

Genetic immune deficiency could hold key to severe childhood infections

July 18, 2017
A gene mutation making young children extremely vulnerable to common viruses may represent a new type of immunodeficiency, according to a University of Queensland researcher.

What are the best ways to diagnose and manage asthma?

July 18, 2017
What are the best ways to diagnose and manage asthma in adults? This can be tricky because asthma can stem from several causes and treatment often depends on what is triggering the asthma.

Large multi-ethnic study identifies many new genetic markers for lupus

July 17, 2017
Scientists from an international consortium have identified a large number of new genetic markers that predispose individuals to lupus.

Study finds molecular explanation for struggles of obese asthmatics

July 17, 2017
A large, bouquet-shaped molecule called surfactant protein A, or SP-A, may explain why obese asthma patients have harder-to-treat symptoms than their lean and overweight counterparts, according to a new study led by scientists ...

Team identifies potential cause for lupus

July 14, 2017
Leading rheumatologist and Feinstein Institute for Medical Research Professor Betty Diamond, MD, may have identified a protein as a cause for the adverse reaction of the immune system in patients suffering from lupus. A better ...

Immunosuppression underlies resistance to anti-angiogenic therapy

July 14, 2017
A Massachusetts General Hospital (MGH) research team has identified a novel mechanism behind resistance to angiogenesis inhibitors - drugs that fight cancer by suppressing the formation of new blood vessels. In their report ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.